Literature DB >> 3587745

Ethoxyresorufin O-deethylase activity in rat brain subcellular fractions.

B Walther, J F Ghersi-Egea, Z Jayyosi, A Minn, G Siest.   

Abstract

Non-polar, lipid-soluble drugs or xenobiotics are able to cross the blood-brain barrier. The brain cytochrome P-450-dependent monooxygenases may oxidize these molecules to more polar and somewhat hazardous metabolites responsible for neurotoxicity. In order to characterize the cytochrome P-450 dependent aryl hydrocarbon hydroxylase activity in brain subcellular fractions, we used 7-ethoxyresorufin as a substrate, as its O-deethylation reflects specifically the activity of the cytochrome P-450 isoform which metabolizes and is induced by polycyclic aromatic hydrocarbons. The results reported here show that this enzymatic activity occurs in both microsomal and mitochondrial fractions, and that the induction after 3-methylcholanthrene treatment remains limited, thus preventing the formation of high levels of harmful metabolites.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3587745     DOI: 10.1016/0304-3940(87)90192-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress.

Authors:  P Lagrange; R D El-Bachá; P Netter; A Minn
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

2.  Pharmacological and toxicological significance of brain cytochromes P450.

Authors:  V Ravindranath
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

Review 3.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

4.  Immunohistochemical distribution of cytochrome P4501A in larvae and fingerlings of the Siberian sturgeon, Acipenser baeri.

Authors:  C Sarasquete; J B Ortiz; E Gisbert
Journal:  Histochem J       Date:  2001-02

5.  NADPH:cytochrome P-450(c) reductase: biochemical characterization in rat brain and cultured neurons and evolution of activity during development.

Authors:  J F Ghersi-Egea; A Minn; J L Daval; Z Jayyosi; V Arnould; H Souhaili-El Amri; G Siest
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

6.  Distribution and induction of cytochrome P450 1A1 in the rainbow trout brain.

Authors:  T Andersson; A Goksøyr
Journal:  Fish Physiol Biochem       Date:  1994-10       Impact factor: 2.794

7.  Inducibility of rat brain drug-metabolizing enzymes.

Authors:  J F Ghersi-Egea; B Walther; R Perrin; A Minn; G Siest
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Oct-Dec       Impact factor: 2.441

8.  Cytochrome P450 1B1 mRNA in the human central nervous system.

Authors:  C R Rieder; D B Ramsden; A C Williams
Journal:  Mol Pathol       Date:  1998-06

9.  Substituted xanthones as selective and reversible monoamine oxidase A (MAO-A) inhibitors.

Authors:  U Thull; S Kneubühler; B Testa; M F Borges; M M Pinto
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

10.  Structure-metabolism relationships in the hydrolysis of nicotinate esters by rat liver and brain subcellular fractions.

Authors:  A Durrer; B Walther; A Racciatti; G Boss; B Testa
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.